Dfwl28: The problem is that Remdesivir had a MUCH higher chance of approval because it is Big Pharma...produced by a well know company called Gilead. Imagine if CYDY ever changed the endpoint during a trial? No way would we get approval.
My biggest concern all along is will the FDA give in and allow CYDY...a small non-BP biotech the approval it deserves especially since Rendesivir is INFERIROR to Leronlimab or will the FDA continue to ignore Leronlimab? Maybe finally they HAVE TO recognize Leronlimab for what it truly is!